US Stock Insider Trading | Mesa Laboratories Disclosed Two Insider Transactions on March 10

K-LinePoet · 2026-03-23T00:37:51+00:00

On March 10, 2026, directors Tripeny R Tony and Capone Mark Christopher of Mesa Laboratories purchased 1315 shares and 1301 shares respectively, with total transaction amounts close to $200,000. The company focuses on quality control products and serves multiple industries including medical and pharmaceutical sectors.

K-LinePoet

2026-03-23 00:37:51

Abstract generation in progress

On March 10, 2026, Mesa Laboratories (MLAB) disclosed two insider transactions. Director Tripeny R Tony purchased 1,315 shares.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 10, 2026	Director	Capone Mark Christopher	March 10, 2026	Buy	1,301	76.35	$99,300
March 10, 2026	Director	Tripeny R Tony	March 10, 2026	Buy	1,315	76.00	$99,900
June 25, 2025	Executive	Sakys John	June 21, 2025	Buy	582	95.82	$55,800
June 25, 2025	Executive	Archbold Brian David	June 21, 2025	Buy	459	95.82	$44,000
June 24, 2025	Executive	Owens Gary M	June 21, 2025	Buy	1,856	95.82	$177,800
June 20, 2025	Executive	Archbold Brian David	June 18, 2025	Buy	1,390	92.99	$129,300
June 20, 2025	Executive	Sakys John	June 18, 2025	Buy	1,597	92.99	$148,500
June 20, 2025	Executive	Owens Gary M	June 18, 2025	Buy	4,897	92.99	$455,400
June 18, 2025	Executive	Archbold Brian David	June 16, 2025	Sell	472	97.12	$48,500
June 18, 2025	Executive	Owens Gary M	June 16, 2025	Sell	1,939	97.12	$188,300

[Company Information]

Mesa Laboratories, Inc. was incorporated on March 26, 1982, under Colorado law. The company’s strategy focuses on control quality products driven by regulation, sold into niche markets. The company prefers markets with limited competition where it can establish authority and achieve high profit margins. The company has two divisions located in four different locations. The Instruments division primarily designs, manufactures, and sells quality control instruments and disposable products related to healthcare, pharmaceuticals, food and beverage, medical devices, industrial hygiene, semiconductors, and petrochemicals. The Bioindicators division mainly manufactures and promotes biological indicators and distributes chemical indicators used to evaluate sterilization processes, including steam, gas, hydrogen peroxide, and radiation in hospitals, dental clinics, medical device, and pharmaceutical industries.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes